Influence of heme oxygenase 1 modulation on the progression of murine collagen‐induced arthritis
Open Access
- 30 September 2005
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 52 (10) , 3230-3238
- https://doi.org/10.1002/art.21356
Abstract
Objective Heme oxygenase 1 (HO-1) can be induced by inflammatory mediators as an adaptive response. The objective of the present study was to determine the consequences of HO-1 modulation in the murine collagen-induced arthritis (CIA) model. Methods DBA/1J mice were treated with an inhibitor of HO-1, tin protoporphyrin IX (SnPP), or with an inducer of HO-1, cobalt protoporphyrin IX (CoPP), from day 22 to day 29 after CIA induction. The clinical evolution of disease was monitored visually. At the end of the experiment, joints were examined for histopathologic changes. Cytokine levels in paws were measured by enzyme-linked immunosorbent assay. Levels of HO-1, cyclooxygenase 2 (COX-2), and prostaglandin E2 (PGE2) were determined. Effects of treatments on the early phase of disease and after prophylactic administration were also assessed. Results CoPP strongly induced HO-1, resulting in the inhibition of cartilage erosion accompanied by extensive fibrosis in the joint. Levels of tumor necrosis factor α (TNFα), interleukin-2 (IL-2), and IL-10 were inhibited by CoPP, whereas levels of vascular endothelial growth factor were increased. Treatment with SnPP significantly reduced the severity of CIA, with inhibition of joint inflammation and cartilage destruction. The levels of PGE2, IL-1β, and TNFα were also significantly reduced by SnPP treatment, which did not modify COX-2 protein expression. SnPP was more effective than CoPP in preventing the development of CIA (prophylactic administration). Conclusion HO-1 is induced during CIA. Although overexpression of this protein causes some beneficial effects, strategies aimed at HO-1 overexpression cannot slow the progression of the chronic inflammatory disease, whereas treatment with SnPP, which inhibits HO-1, exerts prophylactic and therapeutic effects.Keywords
This publication has 46 references indexed in Scilit:
- Biliverdin, a natural product of heme catabolism, induces tolerance to cardiac allograftsThe FASEB Journal, 2004
- Expression profiling of IL‐10‐regulated genes in human monocytes and peripheral blood mononuclear cells from psoriatic patients during IL‐10 therapyEuropean Journal of Immunology, 2004
- Beneficial Effects of Heme Oxygenase-1 Up-Regulation in the Development of Experimental Inflammation Induced by ZymosanThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in miceNature Medicine, 2002
- Transfer of Heme Oxygenase 1 cDNA by a Replication-Deficient Adenovirus Enhances Interleukin 10 Production from Alveolar Macrophages That Attenuates Lipopolysaccharide-Induced Acute Lung Injury in MiceHuman Gene Therapy, 2001
- Enhanced expression of haem oxygenase‐1 by nitric oxide and antiinflammatory drugs in NIH 3T3 fibroblastsBritish Journal of Pharmacology, 2000
- Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor α blockade in patients with rheumatoid arthritisArthritis & Rheumatism, 2000
- The rationale for the current boom in anti-TNFα treatment. Is there an effective means to define therapeutic targets for drugs that provide all the benefits of anti-TNFα and minimise hazards?Annals of the Rheumatic Diseases, 1999
- DNA damage and stress protein synthesis induced by oxidative stress proceed independently in the human premonocytic line U937Mutation Research/DNA Repair, 1994
- Electrical charge of the antigen determines intraarticular antigen handling and chronicity of arthritis in mice.Journal of Clinical Investigation, 1984